Barbara Jean Anne Bormann Kennedy Xeris Biopharma Holdings, Inc. (XERS) insider trading activity

Barbara Jean Anne Bormann Kennedy is Director of Xeris Biopharma Holdings, Inc.. Currently has a direct ownership of 142,500 shares of XERS, which is worth approximately $1.03 Million. The most recent transaction as insider was on Dec 12, 2025, when has been sold 15,000 shares (Common Stock) at a price of $7.09 per share, resulting in proceeds of $106,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 143K

9.52% 3M change

32.56% 12M change

Total Value Held $1.03 Million

BARBARA-JEAN ANNE BORMANN-KENNEDY Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 12 2025	SELL Open market or private sale	$106,350 $7.09 p/Share	15,000 Reduced 9.52%	142,500 Common Stock
Jun 04 2025	BUY Grant, award, or other acquisition	-	50,000 Added 24.1%	157,500 Common Stock
Jun 05 2024	BUY Grant, award, or other acquisition	-	50,000 Added 31.75%	107,500 Common Stock
Jun 07 2023	BUY Grant, award, or other acquisition	-	42,500 Added 42.5%	57,500 Common Stock
Jun 08 2022	BUY Grant, award, or other acquisition	$31,500 $2.1 p/Share	15,000 Added 50.0%	15,000 Common Stock

Also insider at

XERS

XERIS PHARMACEUTICALS INC Healthcare

Director

BAB